Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

JEREMY B SANDERS

Allopathic & Osteopathic Physicians Psychiatry & Neurology Psychiatry

NPI
1093213217
CMS profile
5669280
Location
BROUSSARD, LA

General Payments · PY2024

$501.29

  • Reported across 17 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$501.29

17 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $489.42 16
Education $11.87 1

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Vanda Pharmaceuticals Inc. $282.31 10
ITI, Inc. $116.19 2
Otsuka America Pharmaceutical, Inc. $42.32 2
ABBVIE INC. $37.50 2
Supernus Pharmaceuticals, Inc. $22.97 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2024 $501.29 17

Payment records · PY2024 (17)

Sorted by paying entity, then date · as published by CMS

Program year 2024
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $22.33 08/22/2024 Food and Beverage Undisputed 01/23/2026 1106013655 CMS
ABBVIE INC. $15.17 10/24/2024 Food and Beverage Undisputed 01/23/2026 1106013657 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $92.60 10/23/2024 Food and Beverage Undisputed 01/23/2026 1143597817 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $23.59 10/31/2024 Food and Beverage Undisputed 01/23/2026 1143597821 CMS
Otsuka America Pharmaceutical, Inc. $19.71 08/01/2024 Food and Beverage Undisputed 01/23/2026 1119178852 CMS
Otsuka America Pharmaceutical, Inc. $22.61 10/17/2024 Food and Beverage Undisputed 01/23/2026 1119178854 CMS
Supernus Pharmaceuticals, Inc. $22.97 08/30/2024 Food and Beverage Undisputed 01/23/2026 1147841845 CMS
Vanda Pharmaceuticals Inc. $27.72 09/12/2024 Food and Beverage Undisputed 01/23/2026 1133968011 CMS
Vanda Pharmaceuticals Inc. $126.89 09/25/2024 Food and Beverage Undisputed 01/23/2026 1133968013 CMS
Vanda Pharmaceuticals Inc. $26.91 10/03/2024 Food and Beverage Undisputed 01/23/2026 1133968015 CMS
Vanda Pharmaceuticals Inc. $6.31 10/15/2024 Food and Beverage Undisputed 01/23/2026 1133968017 CMS
Vanda Pharmaceuticals Inc. $22.01 10/30/2024 Food and Beverage Undisputed 01/23/2026 1133968019 CMS
Vanda Pharmaceuticals Inc. $16.65 11/05/2024 Food and Beverage Undisputed 01/23/2026 1133968021 CMS
Vanda Pharmaceuticals Inc. $8.16 11/14/2024 Food and Beverage Undisputed 01/23/2026 1133968023 CMS
Vanda Pharmaceuticals Inc. $7.19 12/03/2024 Food and Beverage Undisputed 01/23/2026 1133968025 CMS
Vanda Pharmaceuticals Inc. $11.87 12/16/2024 Education Undisputed 01/23/2026 1133968027 CMS
Vanda Pharmaceuticals Inc. $28.60 12/19/2024 Food and Beverage Undisputed 01/23/2026 1133968029 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2024
Source files
Dataset page · Bulk file · PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.